AS703569

DRUG2 trials

Sponsors

EMD Serono

Conditions

Haematological MalignanciesSolid Tumors

Phase 1

AS703569 Phase I in Patients With Solid Tumours

CompletedNCT00391521

EMD SeronoSolid Tumors

Start: 2006-08-31End: 2010-06-30Updated: 2014-01-30

A Phase I, Dose-escalation Study of AS703569 Given Orally to Subjects With Haematological Malignancies

TerminatedNCT01080664

EMD SeronoHaematological Malignancies

Start: 2006-12-31End: 2011-08-31Updated: 2013-10-22